The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Early Cancer Detection-Global Market Insights and Sales Trends 2024
Synopsis
Body fluid samples were collected for early cancer detection, and CTC, ctDNA and other markers were captured to evaluate the tumor situation. It is non-invasive, efficient, sensitive and highly acceptable for patients.
The global Early Cancer Detection market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Early Cancer Detection in various end use industries. The expanding demands from the Hospital, Clinic and Others,, are propelling Early Cancer Detection market. ctDNA, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the CTC segment is estimated at % CAGR for the next seven-year period.
The early cancer detection market is a rapidly evolving sector within the healthcare industry. Early detection of cancer is crucial for improving treatment outcomes and reducing mortality rates. Detecting cancer at an earlier stage allows for more effective treatment options and increases the chances of successful recovery.
Various screening technologies are used for early cancer detection, including imaging techniques like mammography for breast cancer, colonoscopy for colorectal cancer, Pap smear for cervical cancer, and PSA blood test for prostate cancer. These screening methods have been widely adopted and are proven to be effective in detecting cancer at an early stage.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Early Cancer Detection, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Early Cancer Detection market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Early Cancer Detection market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Early Cancer Detection sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Early Cancer Detection covered in this report include GRAIL(Illumina), Exact Sciences, Guardant Health, BGI, New Horizon Health, Epigenomics AG, Genetron Health and Berry Genomics, etc.
The global Early Cancer Detection market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GRAIL(Illumina)
Exact Sciences
Guardant Health
BGI
New Horizon Health
Epigenomics AG
Genetron Health
Berry Genomics
Global Early Cancer Detection market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Early Cancer Detection market, Segment by Type:
ctDNA
CTC
Exosomes
Circulating protein
Global Early Cancer Detection market, by Application
Hospital
Clinic
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Early Cancer Detection companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Body fluid samples were collected for early cancer detection, and CTC, ctDNA and other markers were captured to evaluate the tumor situation. It is non-invasive, efficient, sensitive and highly acceptable for patients.
The global Early Cancer Detection market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Early Cancer Detection in various end use industries. The expanding demands from the Hospital, Clinic and Others,, are propelling Early Cancer Detection market. ctDNA, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the CTC segment is estimated at % CAGR for the next seven-year period.
The early cancer detection market is a rapidly evolving sector within the healthcare industry. Early detection of cancer is crucial for improving treatment outcomes and reducing mortality rates. Detecting cancer at an earlier stage allows for more effective treatment options and increases the chances of successful recovery.
Various screening technologies are used for early cancer detection, including imaging techniques like mammography for breast cancer, colonoscopy for colorectal cancer, Pap smear for cervical cancer, and PSA blood test for prostate cancer. These screening methods have been widely adopted and are proven to be effective in detecting cancer at an early stage.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Early Cancer Detection, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Early Cancer Detection market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Early Cancer Detection market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Early Cancer Detection sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Early Cancer Detection covered in this report include GRAIL(Illumina), Exact Sciences, Guardant Health, BGI, New Horizon Health, Epigenomics AG, Genetron Health and Berry Genomics, etc.
The global Early Cancer Detection market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GRAIL(Illumina)
Exact Sciences
Guardant Health
BGI
New Horizon Health
Epigenomics AG
Genetron Health
Berry Genomics
Global Early Cancer Detection market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Early Cancer Detection market, Segment by Type:
ctDNA
CTC
Exosomes
Circulating protein
Global Early Cancer Detection market, by Application
Hospital
Clinic
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Early Cancer Detection companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Early Cancer Detection
1.1 Early Cancer Detection Market Overview
1.1.1 Early Cancer Detection Product Scope
1.1.2 Early Cancer Detection Market Status and Outlook
1.2 Global Early Cancer Detection Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Early Cancer Detection Market Size by Region (2018-2029)
1.4 Global Early Cancer Detection Historic Market Size by Region (2018-2023)
1.5 Global Early Cancer Detection Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Early Cancer Detection Market Size (2018-2029)
1.6.1 North America Early Cancer Detection Market Size (2018-2029)
1.6.2 Europe Early Cancer Detection Market Size (2018-2029)
1.6.3 Asia-Pacific Early Cancer Detection Market Size (2018-2029)
1.6.4 Latin America Early Cancer Detection Market Size (2018-2029)
1.6.5 Middle East & Africa Early Cancer Detection Market Size (2018-2029)
2 Early Cancer Detection Market by Type
2.1 Introduction
2.1.1 ctDNA
2.1.2 CTC
2.1.3 Exosomes
2.1.4 Circulating protein
2.2 Global Early Cancer Detection Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Early Cancer Detection Historic Market Size by Type (2018-2023)
2.2.2 Global Early Cancer Detection Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Early Cancer Detection Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Early Cancer Detection Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Early Cancer Detection Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Early Cancer Detection Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Early Cancer Detection Revenue Breakdown by Type (2018-2029)
3 Early Cancer Detection Market Overview by Application
3.1 Introduction
3.1.1 Hospital
3.1.2 Clinic
3.1.3 Others
3.2 Global Early Cancer Detection Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Early Cancer Detection Historic Market Size by Application (2018-2023)
3.2.2 Global Early Cancer Detection Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Early Cancer Detection Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Early Cancer Detection Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Early Cancer Detection Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Early Cancer Detection Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Early Cancer Detection Revenue Breakdown by Application (2018-2029)
4 Early Cancer Detection Competition Analysis by Players
4.1 Global Early Cancer Detection Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Early Cancer Detection as of 2022)
4.3 Date of Key Players Enter into Early Cancer Detection Market
4.4 Global Top Players Early Cancer Detection Headquarters and Area Served
4.5 Key Players Early Cancer Detection Product Solution and Service
4.6 Competitive Status
4.6.1 Early Cancer Detection Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 GRAIL(Illumina)
5.1.1 GRAIL(Illumina) Profile
5.1.2 GRAIL(Illumina) Main Business
5.1.3 GRAIL(Illumina) Early Cancer Detection Products, Services and Solutions
5.1.4 GRAIL(Illumina) Early Cancer Detection Revenue (US$ Million) & (2018-2023)
5.1.5 GRAIL(Illumina) Recent Developments
5.2 Exact Sciences
5.2.1 Exact Sciences Profile
5.2.2 Exact Sciences Main Business
5.2.3 Exact Sciences Early Cancer Detection Products, Services and Solutions
5.2.4 Exact Sciences Early Cancer Detection Revenue (US$ Million) & (2018-2023)
5.2.5 Exact Sciences Recent Developments
5.3 Guardant Health
5.3.1 Guardant Health Profile
5.3.2 Guardant Health Main Business
5.3.3 Guardant Health Early Cancer Detection Products, Services and Solutions
5.3.4 Guardant Health Early Cancer Detection Revenue (US$ Million) & (2018-2023)
5.3.5 BGI Recent Developments
5.4 BGI
5.4.1 BGI Profile
5.4.2 BGI Main Business
5.4.3 BGI Early Cancer Detection Products, Services and Solutions
5.4.4 BGI Early Cancer Detection Revenue (US$ Million) & (2018-2023)
5.4.5 BGI Recent Developments
5.5 New Horizon Health
5.5.1 New Horizon Health Profile
5.5.2 New Horizon Health Main Business
5.5.3 New Horizon Health Early Cancer Detection Products, Services and Solutions
5.5.4 New Horizon Health Early Cancer Detection Revenue (US$ Million) & (2018-2023)
5.5.5 New Horizon Health Recent Developments
5.6 Epigenomics AG
5.6.1 Epigenomics AG Profile
5.6.2 Epigenomics AG Main Business
5.6.3 Epigenomics AG Early Cancer Detection Products, Services and Solutions
5.6.4 Epigenomics AG Early Cancer Detection Revenue (US$ Million) & (2018-2023)
5.6.5 Epigenomics AG Recent Developments
5.7 Genetron Health
5.7.1 Genetron Health Profile
5.7.2 Genetron Health Main Business
5.7.3 Genetron Health Early Cancer Detection Products, Services and Solutions
5.7.4 Genetron Health Early Cancer Detection Revenue (US$ Million) & (2018-2023)
5.7.5 Genetron Health Recent Developments
5.8 Berry Genomics
5.8.1 Berry Genomics Profile
5.8.2 Berry Genomics Main Business
5.8.3 Berry Genomics Early Cancer Detection Products, Services and Solutions
5.8.4 Berry Genomics Early Cancer Detection Revenue (US$ Million) & (2018-2023)
5.8.5 Berry Genomics Recent Developments
6 North America
6.1 North America Early Cancer Detection Market Size by Country (2018-2029)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Early Cancer Detection Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Early Cancer Detection Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Early Cancer Detection Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Early Cancer Detection Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Early Cancer Detection Market Dynamics
11.1 Early Cancer Detection Industry Trends
11.2 Early Cancer Detection Market Drivers
11.3 Early Cancer Detection Market Challenges
11.4 Early Cancer Detection Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
